Cargando…
Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19
The novel human coronavirus disease (COVID-19) has been associated with vascular and thrombotic complications, some of which may result from endothelial dysfunction, including the posterior reversible encephalopathy syndrome (PRES). We report a case series of 8 patients with COVID-19 and PRES diagno...
Autores principales: | Lallana, Sofía, Chen, Austin, Requena, Manuel, Rubiera, Marta, Sanchez, Anna, Siegler, James E., Muchada, Marián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985961/ https://www.ncbi.nlm.nih.gov/pubmed/33992168 http://dx.doi.org/10.1016/j.jocn.2021.03.028 |
Ejemplares similares
-
Response to correspondence concerning “Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19”
por: Lallana, Sofia, et al.
Publicado: (2021) -
Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017) -
Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020) -
Daptomycin-Induced Posterior Reversible Encephalopathy Syndrome (PRES)
por: Bitar De Zayas-Enriquez, A., et al.
Publicado: (2019) -
Posterior reversible encephalopathy syndrome (PRES) of the isolated brainstem
por: Hayashi, Yosuke, et al.
Publicado: (2022)